Skip to main content
Novonesis AS logo

Novonesis AS — Investor Relations & Filings

Ticker · NSIS ISIN · DK0060336014 LEI · 529900T6WNZXD2R3JW38 CO Manufacturing
Open in API
Filings indexed 2,308 across all filing types
Latest filing 2015-02-16 Transaction in Own Shar…
Country DK Denmark
Listing CO NSIS

About Novonesis AS

https://www.novozymes.com/en

Novonesis is a global biosolutions company formed through the combination of Novozymes and Chr. Hansen. The company develops and produces a broad portfolio of biological solutions, including industrial enzymes, functional proteins, and microorganisms such as cultures, probiotics, and yeast. Its products are utilized in over 30 industries to improve efficiency, sustainability, and product quality. Key markets include food and beverage, where solutions enhance nutrition and reduce waste; human and animal health; agriculture, promoting higher crop yields and animal welfare; and household care, for more effective cleaning. Novonesis applies biotechnological principles to address global challenges in production and consumption, aiming to create more sustainable systems and products.

Recent filings

Filing Released Lang Actions
Transaction in Own Shares 2015
Transaction in Own Shares Classification · 100% confidence The document text explicitly states that Novozymes has purchased an accumulated number of shares under a 'stock buyback program'. This action directly relates to the company managing its own shares, which corresponds to the definition of 'Transaction in Own Shares'. The document is very short and directs the user to read the full announcement in PDF format, but the core content is the transaction itself, making 'POS' (Transaction in Own Shares) the most specific classification over a general 'RPA' or 'RNS'.
2015-02-16 English
Transaction in Own Shares 2015
Transaction in Own Shares Classification · 100% confidence The document text explicitly states that Novozymes has purchased an accumulated number of shares under a 'stock buyback program'. This action directly relates to the company acquiring its own shares. The filing category 'Transaction in Own Shares (POS)' is defined as the report of the company buying back or selling its own shares. Although the text mentions reading the full announcement in PDF format (suggesting RPA/RNS), the core content is the transaction itself, making POS the most specific classification for the subject matter, especially given the very short length which often accompanies these specific transaction disclosures.
2015-02-09 English
Transaction in Own Shares 2015
Transaction in Own Shares Classification · 100% confidence The document text is very short (393 characters) and describes a specific transaction: Novozymes buying back its own shares (aktietilbagekøbsprogram) up to a total value of 2 billion DKK. This directly corresponds to the definition of 'Transaction in Own Shares' (POS), which covers share repurchases. Although it mentions reading the full announcement in PDF format (suggesting RPA/RNS), the core content is the transaction itself, making POS the most specific fit for the content provided, rather than just an announcement *about* a report.
2015-02-09 Danish
Transaction in Own Shares 2015
Transaction in Own Shares Classification · 100% confidence The document text explicitly states that Novozymes will commence a share buyback program ('aktietilbagekøbsprogram') starting February 2, 2015, up to a total value of 2 billion DKK. This directly relates to the company managing its own shares. This aligns perfectly with the definition for 'Transaction in Own Shares' (POS), which covers share repurchases. The document is short and announces the action, but the core subject is the buyback itself, making POS a more specific fit than RPA or RNS.
2015-01-29 Danish
Transaction in Own Shares 2015
Transaction in Own Shares Classification · 100% confidence The document explicitly states that Novozymes will 'initiate a stock buyback program' and details the amount (DKK 2 billion) and duration (remainder of 2015). This directly relates to the company purchasing its own shares. This aligns perfectly with the definition for 'Transaction in Own Shares' (POS). Although it mentions reading the full announcement in PDF format, the core content is the announcement of the buyback itself, making POS a more specific fit than RPA or RNS.
2015-01-29 English
Director's Dealing 2015
Director's Dealing Classification · 95% confidence The document is very short (226 characters) and is written in Danish. It explicitly states that Novozymes is making public transactions according to Section 28a of the Securities Trading Act, referencing ISIN DK0060336014 and Novozymes B shares (NZYM B). It concludes by stating, 'Læs hele meddelelsen i pdf format' (Read the entire announcement in pdf format). This structure—a brief notification pointing to a full PDF—strongly suggests this is an announcement about a filing rather than the filing itself. Since the content relates to transactions by insiders or related parties (implied by the reference to the Securities Trading Act and specific share codes), the most fitting category is Director's Dealing (DIRS). However, given the 'MENU VS MEAL' rule, and the fact that it's a brief announcement pointing to a full document, it could also be a general Regulatory Filing (RNS). Director's Dealing (DIRS) is more specific to the content (transactions under the Securities Trading Act). I will classify it as DIRS, as the content is clearly about insider transactions, even if announced briefly.
2015-01-29 Danish

Browse filings by year

20 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.